Invitation: pdf Deprescribing symposium (39 KB)
Use of evidence-based treatment guidelines support initiationand maintenance of drug treatments. However, many receivemedication that is no longer needed and deprescribing of wellintentionedmedication may be relevant, for instance, due tounacceptable side effects, lack of effect or the like. Deprescribingmay be difficult and until recently, no evidence-baseddeprescribing guidelines have been available.
Evidence-based deprescribing guidelines have now beendeveloped in Canada and Australia as the first in the world.
Keynote speaker:Dr. Barbara Farrell, BScPhm, PharmD, FCSHP, University of Ottawa,one of the initiators of the concept development concerningEvidence Based Deprescribing Guidelines.The symposium is arranged by Medicinfunktionen, KliniskFarmakologisk Afdeling, Bispebjerg Hospital and is held in English.